| An array of 60,000 antibodies for proteome-scale antibody generation and target discovery Z Wang, Y Li, B Hou, MI Pronobis, M Wang, Y Wang, G Cheng, W Weng, ... Science advances 6 (11), eaax2271, 2020 | 28 | 2020 |
| Antibody–exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer W Weng, T Meng, Q Zhao, Y Shen, G Fu, J Shi, Y Zhang, Z Wang, ... Cancer Discovery 13 (4), 950-973, 2023 | 18 | 2023 |
| Application of an antibody chip for screening differentially expressed proteins during peach ripening and identification of a metabolon in the SAM cycle to generate a peach … W Zeng, L Niu, Z Wang, X Wang, Y Wang, L Pan, Z Lu, G Cui, W Weng, ... Horticulture research 7, 2020 | 14 | 2020 |
| AMT-562, a novel HER3-targeting antibody–drug conjugate, demonstrates a potential to broaden therapeutic opportunities for HER3-expressing tumors W Weng, T Meng, J Pu, L Ma, Y Shen, Z Wang, R Pan, M Wang, C Chen, ... Molecular Cancer Therapeutics 22 (9), 1013-1027, 2023 | 6 | 2023 |
| TJP1, a membrane-expressed protein, is a potential therapeutic and prognostic target for lung cancer J Pu, T Ai, W Weng, L Wang, Y Yang, L Ma, Z Hu, X Meng Technology in Cancer Research & Treatment 21, 15330338221106855, 2022 | 3 | 2022 |
| A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody–Drug Conjugate for Targeting Melanoma J Shi, T Jiao, Q Guo, W Weng, L Ma, Q Zhang, L Wang, J Zhang, C Chen, ... Cancer Research 83 (22), 3783-3795, 2023 | 2 | 2023 |
| MTX-13, a Novel PTK7-Directed Antibody–Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors C Kong, J Pu, Q Zhao, W Weng, L Ma, Y Qian, W Hu, X Meng, T Meng Molecular Cancer Therapeutics 22 (10), 1128-1143, 2023 | 1 | 2023 |
